(Q38979806)

8 September 2017

Budget impact analysis of sFlt-1/PlGF ratio as prediction test in Italian women with suspected preeclampsia (English)

1 reference

8 September 2017

0 references

0 references

0 references

Irene Cetin

6

0 references

author name string

Tiziana Frusca

1

1 reference

8 September 2017

Maria-Teresa Gervasi

2

1 reference

8 September 2017

Davide Paolini

3

1 reference

8 September 2017

Matteo Dionisi

4

1 reference

8 September 2017

Francesca Ferre

5

1 reference

8 September 2017

13 October 2016

1 reference

Journal of Maternal-Fetal and Neonatal Medicine

8 September 2017

1 reference

8 September 2017

30

1 reference

8 September 2017

18

1 reference

8 September 2017

2166-2173

1 reference

WHO analysis of causes of maternal death: a systematic review

8 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F14767058.2016.1242122

The global impact of pre-eclampsia and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767058.2016.1242122

Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767058.2016.1242122

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767058.2016.1242122

Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767058.2016.1242122

Competing risks model in screening for preeclampsia by biophysical and biochemical markers at 30-33 weeks' gestation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767058.2016.1242122

PlGF in a clinical setting of pregnancies at risk of preeclampsia and/or intrauterine growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767058.2016.1242122

The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767058.2016.1242122

Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767058.2016.1242122

Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767058.2016.1242122

Clinical management of hypertension in pregnancy. Practical recommendations from the Italian Society of Hypertension (SIIA). [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767058.2016.1242122

sFlt-1/PlGF ratio test for pre-eclampsia: an economic assessment for the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767058.2016.1242122

Influence of pre-eclampsia on fetal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767058.2016.1242122

Direct cost analysis of intensive care unit stay in four European countries: applying a standardized costing methodology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767058.2016.1242122

Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767058.2016.1242122

10.1080/14767058.2016.1242122

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference